All Posts: brain
-
“SNIFF,” a Nasal Insulin Study for Alzheimer’s, Now Underway at Georgetown
WASHINGTON – Georgetown University’s Memory Disorders Program is looking for volunteers to participate in a study to see if insulin, the hormone used to treat diabetes, can improve cognition, memory and daily function in people with mild cognitive impairment or mild dementia due to Alzheimer’s disease.
Category: News Release
-
Georgetown Study Opens for Those With Inherited Genetic Risk for Alzheimer’s Disease
WASHINGTON — The Memory Disorders Program at Georgetown University Medical Center is seeking volunteers to participate in a study testing two agents to slow the onset and progression of Alzheimer’s disease. Cognitively normal individuals with a particular genetic risk of developing the disorder are being sought.
Category: News Release
-
Georgetown, Children’s National Researchers To Evaluate Sesame Workshop’s Autism Initiative
WASHINGTON — Sesame Workshop, the nonprofit educational organization behind Sesame Street, has selected Georgetown University Medical Center and Children’s National Health System researchers to lead an evaluation of “Sesame Street and Autism: See Amazing in All Children,” an initiative developed to reduce stigma and build understanding about autism spectrum disorder (ASD).
Category: News Release
-
First Diagnosed Case of Alzheimer’s Disease in HIV-Positive Individual Reported
WASHINGTON (April 15, 2016) — Georgetown University researchers are reporting the first case of Alzheimer’s disease diagnosed in an HIV-positive individual. The finding in a 71-year-old man triggers a realization about HIV survivors now reaching the age when Alzheimer’s risk begins to escalate. Published online in the open access journal Alzheimer’s & Dementia: Diagnosis, Assessment & Disease […]
Category: News Release
-
Georgetown Hosts Research Summit on Concussions in Females
WASHINGTON — When physicians, researchers and scientists gather at Georgetown University later this month, they will tackle what they say is an underappreciated medical issue: brain concussions in girls and women.
Category: News Release
-
Research Summit Focuses on Female Concussion and Traumatic Brain Injury
PINKconcussions and Georgetown University Medical Center, with support for the NCAA Sports Science Institute and US Lacrosse, are hosting the first summit to explore gender differences of female brain injuries including symptoms, treatment and recovery to develop a better model of care. The International Summit on Female Concussion and Traumatic Brain Injury will be held Saturday, Jan. 27 at Georgetown University.
Category: News Release
-
First-of-Its-Kind Study Explains Why Rest is Critical After A Concussion
Doctors who order several days of rest after a person suffers a concussion are giving sound advice, say researchers, and new data from animal models explains why. Georgetown University Medical Center neuroscientists say rest — for more than a day — is critical for allowing the brain to reset neural networks and repair any short-term injury. The new study in mice also shows that repeated mild concussions with only a day to recover between injuries leads to mounting damage and brain inflammation that remains evident a year after injury.
Category: News Release
-
Could Blood pressure drugs have a role in Alzheimer's Disease treatment?
WASHINGTON — In laboratory neuronal cultures, an FDA-approved drug used to treat high blood pressure reduced cell damage often linked to Alzheimer’s disease, say researchers at Georgetown University Medical Center (GUMC) and the National Institutes of Health.
Category: News Release
-
Brain Wars of Star Wars: Fact or Fiction?
WASHINGTON – “Science fiction is often the driver of science fact.” So says Georgetown neuroethicist James Giordano, PhD, MPhil, when asked about one of the most popular science fiction movies, “Star Wars” and the seventh installment: “Star Wars: The Force Awakens.”
Category: News Release
-
Researchers Report First Therapy Appearing to Reverse Decline in Parkinson’s
OCTOBER 17, 2015 – An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC). The drug, nilotinib (known as Tasigna® by Novartis) also led to statistically significant and encouraging changes in toxic […]
Category: GUMC Stories